<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Comput Toxicol</journal-id><journal-id journal-id-type="iso-abbrev">Comput Toxicol</journal-id><journal-id journal-id-type="pmc-domain-id">445</journal-id><journal-id journal-id-type="pmc-domain">elsevierwt</journal-id><journal-title-group><journal-title>Computational Toxicology (Amsterdam, Netherlands)</journal-title></journal-title-group><issn pub-type="epub">2468-1113</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Elsevier Sponsored Documents</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6559215</article-id><article-id pub-id-type="pmcid-ver">PMC6559215.1</article-id><article-id pub-id-type="pmcaid">6559215</article-id><article-id pub-id-type="pmcaiid">6559215</article-id><article-id pub-id-type="pmid">31218267</article-id><article-id pub-id-type="doi">10.1016/j.comtox.2018.09.001</article-id><article-id pub-id-type="publisher-id">S2468-1113(18)30114-2</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Role of Physiologically Based Kinetic modelling in addressing environmental chemical mixtures &#8211; A review</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Desalegn</surname><given-names initials="A">Anteneh</given-names></name><xref rid="fn1" ref-type="fn">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bopp</surname><given-names initials="S">Stephanie</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Asturiol</surname><given-names initials="D">David</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lamon</surname><given-names initials="L">Lara</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Worth</surname><given-names initials="A">Andrew</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Paini</surname><given-names initials="A">Alicia</given-names></name><email>alicia.paini@ec.europa.eu</email><xref rid="cor1" ref-type="corresp">&#8270;</xref></contrib></contrib-group><aff id="af005"><label>a</label>European Commission, Joint Research Centre, Ispra, VA, Italy</aff><author-notes><corresp id="cor1"><label>&#8270;</label>Corresponding author at: European Commission, Joint Research Centre, Via E. Fermi 2749, 21027 Ispra, VA, Italy. <email>alicia.paini@ec.europa.eu</email></corresp><fn id="fn1"><label>1</label><p id="np9010">Present address: Department of Environmental Exposure and Epidemiology, Norwegian Institute of Public Health, Oslo, Norway.</p></fn></author-notes><pub-date pub-type="epub"><month>5</month><year>2019</year></pub-date><volume>10</volume><issue-id pub-id-type="pmc-issue-id">336057</issue-id><fpage>158</fpage><lpage>168</lpage><history><date date-type="received"><day>9</day><month>6</month><year>2017</year></date><date date-type="rev-recd"><day>24</day><month>6</month><year>2018</year></date><date date-type="accepted"><day>26</day><month>9</month><year>2018</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>05</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>17</day><month>06</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-06-29 08:56:14.227"><day>29</day><month>06</month><year>2019</year></date></event></pub-history><permissions><copyright-statement>&#169; 2018 The Authors</copyright-statement><copyright-year>2018</copyright-year><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract abstract-type="author-highlights" id="ab005"><title>Highlights</title><p><list list-type="simple" id="l0005"><list-item id="o0005"><label>&#8226;</label><p id="p0005">The availability and applicability of Physiologically Based Kinetic (PBK) models for mixtures is reviewed.</p></list-item><list-item id="o0010"><label>&#8226;</label><p id="p0010">PBK models can support risk assessment of mixtures by incorporating the toxicokinetic processes.</p></list-item><list-item id="o0015"><label>&#8226;</label><p id="p0015">Quantitative structure-activity relationship (QSAR) models can be used to fill data gaps in PBK modelling.</p></list-item><list-item id="o0020"><label>&#8226;</label><p id="p0020">PBK models for mixtures can be improved by including various types of interactions.</p></list-item></list></p></abstract><abstract id="ab010"><p>The role of Physiologically Based Kinetic (PBK) modelling in assessing mixture toxicology has been growing for the last three decades. It has been widely used to investigate and address interactions in mixtures. This review describes the current state-of-the-art of PBK models for chemical mixtures and to evaluate the applications of PBK modelling for mixtures with emphasis on their role in chemical risk assessment. A total of 35 mixture PBK models were included after searching web resources (Scopus, PubMed, Web of Science, and Google Scholar), screening for duplicates, and excluding articles based on eligibility criteria. Binary mixtures and volatile organic compounds accounted for two-thirds of the chemical mixtures identified. The most common exposure route and modelled system were found to be inhalation and rats respectively. Twenty two (22) models were for binary mixtures, 5 for ternary mixtures, 3 for quaternary mixtures, and 5 for complex mixtures. Both bottom-up and top-down PBK modelling approaches are described. Whereas bottom-up approaches are based on a series of binary interactions, top-down approaches are based on the lumping of mixture components. Competitive inhibition is the most common type of interaction among the various types of mixtures, and usually becomes a concern at concentrations higher than environmental exposure levels. It leads to reduced biotransformation that either means a decrease in the amount of toxic metabolite formation or an increase in toxic parent chemical accumulation. The consequence is either lower or higher toxicity compared to that estimated for the mixture based on the additivity principle. Therefore, PBK modelling can play a central role in predicting interactions in chemical mixture risk assessment.</p></abstract><kwd-group id="kg005"><title>Keywords</title><kwd>Physiologically based pharmacokinetic modelling</kwd><kwd>PBPK</kwd><kwd>Mixture</kwd><kwd>Interaction</kwd><kwd>Toxicokinetic interaction</kwd><kwd>Pharmacokinetics</kwd><kwd>Biokinetics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s0005"><label>1</label><title>Introduction</title><p id="p0025">Humans and the environment are exposed to an ever-increasing number of anthropogenic chemicals and to mixtures of chemicals via food, water, air, consumer products etc. However, chemical risk assessment is usually performed for individual substances <xref rid="b0005" ref-type="bibr">[1]</xref>. The risk assessment of chemical mixtures is particularly challenging due to the (often large) number of chemicals combined in mixtures, limited knowledge on mixture composition, the toxicokinetics and toxicodynamics of mixture components, and the (large) number of potential interactions within a chemical mixture <xref rid="b0005" ref-type="bibr">[1]</xref>, <xref rid="b0010" ref-type="bibr">[2]</xref>.</p><p id="p0030">The legal requirements for risk assessment of mixtures depend on the type of mixture and sector. A prospective risk assessment is required for intentional mixtures, e.g., pesticide formulations and multi-component food additives, while it is generally not required for unintentional mixtures <xref rid="b0005" ref-type="bibr">[1]</xref>. There are growing numbers of methods and novel tools under development that enable understanding of the underlying mechanisms of action and interactions in a mixture. Integrated use of these novel tools (<italic toggle="yes">omics, in silico</italic> approaches, Adverse Outcome Pathways (AOPs), TK modelling) has been shown to hold high potential to support risk assessment of mixtures <xref rid="b0005" ref-type="bibr">[1]</xref>, <xref rid="b0015" ref-type="bibr">[3]</xref>.</p><p id="p0035">Two main models are currently used to assess chemical mixtures in a component-based way. These are <italic toggle="yes">Concentration addition</italic> (CA) and <italic toggle="yes">Independent action</italic> (IA). These models are the default approaches in regulatory risk assessment <xref rid="b0015" ref-type="bibr">[3]</xref>, <xref rid="b0020" ref-type="bibr">[4]</xref>. CA is applicable to mixtures composed of chemicals with a similar mode of action, where the overall mixture toxicity equals the sum of the potency-corrected exposure concentrations of individual chemicals. On the other hand, IA (also known as response addition) is applicable to chemicals with dissimilar modes of action. In IA-based approaches, the mixture toxicity will not occur if the individual chemicals are all present at sub-toxic levels, whereas in CA-based approaches all components contribute to the total toxicity depending on their concentration and potency. Both CA and IA are based on the assumption that the components within a mixture have no interactions with each other <xref rid="b0025" ref-type="bibr">[5]</xref>.</p><p id="p0040">The magnitude of toxicity of some mixtures cannon be explained by CA or IA. In such cases, the components of the mixture influence one another so that the overall toxicity of a mixture is higher or lower than predicted based on additivity. This phenomenon, known as an interaction, can affect both the toxicokinetics (TK) and toxicodynamics (TD) of chemical mixtures in the body. TK interactions are assumed to influence chemicals during the absorption, distribution, metabolism and excretion (ADME) phase within the body, i.e., due to alteration of absorption, induction/inhibition of metabolising enzymes, alteration of physiological barriers, and factors affecting plasma protein binding or excretion. The consequences of TK interactions are usually either an increased or decreased concentration of one or more chemicals at the site of action, which affects the overall toxicity of the mixture (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). In general, interactions in a mixture lead to either greater effect (synergism, potentiation) or lower effects (antagonism, inhibition) compared to predictions based on CA or IA (<xref rid="f0005" ref-type="fig">Fig. 1</xref>) <xref rid="b0015" ref-type="bibr">[3]</xref>, <xref rid="b0025" ref-type="bibr">[5]</xref>, <xref rid="b0030" ref-type="bibr">[6]</xref>.<fig id="f0005" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Schematic representation of exposure to chemical mixtures and consequences of toxicokinetic and toxicodynamic interactions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p><p id="p0045">Various approaches have been developed to address the role of interactions in predicting combined effects of mixtures. Adjusted/Weight of evidence Hazard Index (HI) and Physiologically Based Kinetic (PBK) modelling are two of the methodologies that can be used to assess interactions in chemical mixtures <xref rid="b0025" ref-type="bibr">[5]</xref>.</p><p id="p0050">PBK models are represented by set of mass-balance differential equations describing the biokinetic processes of a chemical in the body as a function of physicochemical parameters (e.g., partition coefficient), biochemical parameters (e.g., Michaelis&#8211;Menten kinetics: metabolic rate constant, Vmax, and constant, Km), and physiological parameters (e.g., flow, volume). A PBK model has several advantages compared to classical PK modelling approaches, and may be used for various purposes, such as more reliable prediction of the internal dose, supporting biological monitoring, species extrapolation, route-route extrapolation, estimation of response from varying exposure conditions, and estimation of human variability <xref rid="b0035" ref-type="bibr">[7]</xref>, <xref rid="b0040" ref-type="bibr">[8]</xref>, <xref rid="b0045" ref-type="bibr">[9]</xref>. Numerous PBK models have been developed by the scientific community in the last 30&#8239;years, as reviewed by Lu et al. <xref rid="b0050" ref-type="bibr">[10]</xref>. Guidance documents have been developed on best practices on how to build, report, and use these models <xref rid="b0035" ref-type="bibr">[7]</xref>, <xref rid="b0045" ref-type="bibr">[9]</xref>.</p><p id="p0055">The role of PBK modelling in assessing mixture toxicity has evolved over the last three decades, by increasingly taking into account the individual responses of mixture constituents and their interactions. The chemicals present in a mixture interact with each other via different mechanisms. In this review, most of the interactions identified take place at the level of toxicokinetics of two or more chemicals. PBK modelling has been widely used to investigate mechanisms of interactions of chemicals in mixtures <xref rid="b0025" ref-type="bibr">[5]</xref>, <xref rid="b0030" ref-type="bibr">[6]</xref>. The purpose of this review is to identify the present state-the-of-the art of PBK models for mixtures and to highlight their role in assessing interactions between environmental chemicals. This review also highlights opportunities and challenges associated with the use of PBK models in the assessment of mixtures.</p></sec><sec id="s0010"><label>2</label><title>Methodology</title><p id="p0060">The literature search strategy aimed at finding literature published in English on mixture PBK models. For this, a two-step search strategy was carried out to find relevant articles until December 15, 2016. First, a search was conducted on Scopus, PubMed, Web of Sciences, and Google Scholar for titles and abstracts using combination of the following key words, i.e., mixtures, combinations, Physiological Based Pharmacokinetic/Toxicokinetic/Biokinetic modelling, and interactions. Hits obtained in the first step were complemented using bibliographies of relevant literature to add studies missed during the initial phase. The identified articles were further screened for duplicates, and full-text articles were retrieved. Then, exclusion criteria were applied to further screen articles that did not contain PBK model structures or equations, and PBK models that did not apply to two or more chemicals. In the final step, data were extracted following an excel template prepared to collect relevant information, such as class of chemicals, lists of chemicals, number of compartments, types of interaction. The complete list of the relevant articles and extracted information used in this review can be found in the <xref rid="s0090" ref-type="sec">Supplementary material 1</xref> while <xref rid="f0010" ref-type="fig">Fig. 2</xref> summarises the steps followed to implement the search strategy.<fig id="f0010" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Flow chart depicting the procedure for selection of studies to include for the review.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig></p></sec><sec id="s0015"><label>3</label><title>Results</title><p id="p0065">In this section, the results of the search are presented and a review and a discussion of the state-of-the-art of PBK modelling will follow.</p><sec id="s0020"><label>3.1</label><title>Main characteristics of identified PBK mixture models</title><p id="p0070">A total of 35 PBK mixture models were included for this review following the search strategy described in the methods section. Binary mixtures and volatile organic compounds accounted for two-thirds of the mixtures reviewed. The most common route of exposure and modelled system in the studies were found to be inhalation and rats, respectively (<xref rid="f0015" ref-type="fig">Fig. 3</xref>).<fig id="f0015" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Summary of the types and classes of mixtures, modeled system, and routes of exposure in the reviewed PBK models.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr3.jpg"/></fig></p></sec><sec id="s0025"><label>3.2</label><title>List of relevant PBK mixture models</title><p id="p0075">A summary of relevant articles for 22 PBK models for binary mixtures is presented in <xref rid="t0005" ref-type="table">Table 1</xref>, whereas <xref rid="t0010" ref-type="table">Table 2</xref> summarises studies for 5 ternary mixtures, 3 quaternary mixtures, and 5 complex mixtures containing 5 or more defined chemicals. The summary tables describe the type of modelled organism/system, routes of exposure, number of compartments in the PBK model, types of interactions captured in the PBK models, as well as the basis for interaction and development of PBK model for various types and classes of mixtures. Competitive inhibition was found to be the most common type of interaction among the various types of mixtures modelled by the PBK models.<table-wrap position="float" id="t0005" orientation="portrait"><label>Table 1</label><caption><p>Summary of relevant PBK models for binary mixtures.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Reference</th><th colspan="1" rowspan="1">Modeled organism</th><th colspan="1" rowspan="1">Class of chemicals</th><th colspan="1" rowspan="1">List of chemicals</th><th colspan="1" rowspan="1">Route of administration</th><th colspan="1" rowspan="1">Number of compartments</th><th colspan="1" rowspan="1">Type/Mechanism of interaction</th><th colspan="1" rowspan="1">Basis of interaction</th><th colspan="1" rowspan="1">Basis of PBK model</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><xref rid="b0125" ref-type="bibr">[25]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Trichloroethylene, 1,1-dichloroethylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Optimal fit in PBK simulation</td><td colspan="1" rowspan="1"><xref rid="b0115" ref-type="bibr">[23]</xref>, <xref rid="b0120" ref-type="bibr">[24]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0140" ref-type="bibr">[28]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Benzene, Toluene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Non-competitive inhibition</td><td colspan="1" rowspan="1">Optimal fit in PBK simulation</td><td colspan="1" rowspan="1"><xref rid="b0115" ref-type="bibr">[23]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0130" ref-type="bibr">[26]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Toluene, m-xylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Best visual fit in PBK simulation</td><td colspan="1" rowspan="1"><xref rid="b0115" ref-type="bibr">[23]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0155" ref-type="bibr">[31]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Kepone, Carbon tetrachloride</td><td colspan="1" rowspan="1">Oral/inhalation</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">Toxicodynamics (potentiation)</td><td colspan="1" rowspan="1"><xref rid="b0215" ref-type="bibr">[44]</xref></td><td colspan="1" rowspan="1"><xref rid="b0220" ref-type="bibr">[45]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0145" ref-type="bibr">[29]</xref></td><td colspan="1" rowspan="1">Human</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Tolune, Xylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Best fit</td><td colspan="1" rowspan="1"><xref rid="b0130" ref-type="bibr">[26]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0145" ref-type="bibr">[29]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Vinyl chloride, Trichloroethylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Best fit</td><td colspan="1" rowspan="1"><xref rid="b0115" ref-type="bibr">[23]</xref>, <xref rid="b0125" ref-type="bibr">[25]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0135" ref-type="bibr">[27]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Tolune, Dichloromethane</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1"><xref rid="b0185" ref-type="bibr">[37]</xref></td><td colspan="1" rowspan="1"><xref rid="b0130" ref-type="bibr">[26]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0225" ref-type="bibr">[46]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Kepone, Carbon tetrachloride</td><td colspan="1" rowspan="1">IP, inhalation</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">Potentiation</td><td colspan="1" rowspan="1"><xref rid="b0215" ref-type="bibr">[44]</xref> in vivo experiment</td><td colspan="1" rowspan="1">PBK/PD modelling earliest example</td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0230" ref-type="bibr">[47]</xref></td><td colspan="1" rowspan="1">Human</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Toluene, n-hexane</td><td colspan="1" rowspan="1">inhalation</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">Non-competitive inhibition</td><td colspan="1" rowspan="1"><italic toggle="yes">In vivo</italic> &amp; <italic toggle="yes">in vitro</italic> Experiments <xref rid="b0235" ref-type="bibr">[48]</xref></td><td colspan="1" rowspan="1"><xref rid="b0240" ref-type="bibr">[49]</xref>, <xref rid="b0245" ref-type="bibr">[50]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0250" ref-type="bibr">[51]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Methylchloroform, m-xylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b0120" ref-type="bibr">[24]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0255" ref-type="bibr">[52]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Toluene, n-hexane</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Non-competitive/ uncompetitive inhibition</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b0120" ref-type="bibr">[24]</xref></td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Human</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Toluene, n-hexane</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Non-competitive or uncompetitive inhibition</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b0120" ref-type="bibr">[24]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0190" ref-type="bibr">[38]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Toluene, Trichloroethylene</td><td colspan="1" rowspan="1">IV</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1"><xref rid="b0130" ref-type="bibr">[26]</xref>, <xref rid="b9010" ref-type="bibr">[75]</xref></td><td colspan="1" rowspan="1"><xref rid="b0130" ref-type="bibr">[26]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0260" ref-type="bibr">[53]</xref></td><td colspan="1" rowspan="1">Human</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Ethylbenzene, Xylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b9015" ref-type="bibr">[76]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0265" ref-type="bibr">[54]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Chloroform, Trichloroethylene</td><td colspan="1" rowspan="1">IV</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"><xref rid="b0120" ref-type="bibr">[24]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0270" ref-type="bibr">[55]</xref></td><td colspan="1" rowspan="1">Mice</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Carbon tetrachloride, Tetrachloroethylene</td><td colspan="1" rowspan="1">Oral</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Suicide inhibition</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b0120" ref-type="bibr">[24]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0275" ref-type="bibr">[56]</xref></td><td colspan="1" rowspan="1">Mice</td><td colspan="1" rowspan="1">PCB</td><td colspan="1" rowspan="1">PCB 153, PCB 126</td><td colspan="1" rowspan="1">Oral</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b0280" ref-type="bibr">[57]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0285" ref-type="bibr">[58]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Pesticides</td><td colspan="1" rowspan="1">Chlorpyrifos, Parathion</td><td colspan="1" rowspan="1">Oral</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">Competitive inhibition at high dose, additivity at low dose</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><xref rid="b0290" ref-type="bibr">[59]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Pesticides</td><td colspan="1" rowspan="1">Chlorpyrifos, Diazinon</td><td colspan="1" rowspan="1">Oral and dermal</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">Non-competitive inhibtion</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1">Individual previous models</td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0165" ref-type="bibr">[33]</xref></td><td colspan="1" rowspan="1">Rat and Human</td><td colspan="1" rowspan="1">Alkenyl benzene</td><td colspan="1" rowspan="1">1'-hydroxyestragole, Nevadensin</td><td colspan="1" rowspan="1">Oral</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">Non-competitive Inhibition</td><td colspan="1" rowspan="1">Experiment and simulation</td><td colspan="1" rowspan="1"><xref rid="b0295" ref-type="bibr">[60]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0170" ref-type="bibr">[34]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Alkenyl benzene</td><td colspan="1" rowspan="1">Estragole, Nevadensin</td><td colspan="1" rowspan="1">Oral</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">Non-competitive inhibition</td><td colspan="1" rowspan="1"><xref rid="b0165" ref-type="bibr">[33]</xref></td><td colspan="1" rowspan="1"><xref rid="b0295" ref-type="bibr">[60]</xref></td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Human</td><td colspan="1" rowspan="1">Alkenyl benzene</td><td colspan="1" rowspan="1">Estragole, Nevadensin</td><td colspan="1" rowspan="1">Oral</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Non-competitive inhibition</td><td colspan="1" rowspan="1"><xref rid="b0165" ref-type="bibr">[33]</xref></td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><xref rid="b0175" ref-type="bibr">[35]</xref></td><td colspan="1" rowspan="1">Rat and Human</td><td colspan="1" rowspan="1">Alkenyl benzene</td><td colspan="1" rowspan="1">7-hydroxycoumarin, Malabaricone C</td><td colspan="1" rowspan="1">Oral</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">Non-competitive inhibition</td><td colspan="1" rowspan="1">Experiment and simulation</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Rat and Human</td><td colspan="1" rowspan="1">Alkenyl benzene</td><td colspan="1" rowspan="1">1'-hydroxysafrole, Malabaricone C</td><td colspan="1" rowspan="1">Oral</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">Non-competitive inhibition</td><td colspan="1" rowspan="1">Experiment and simulation</td><td colspan="1" rowspan="1"/></tr></tbody></table></table-wrap><table-wrap position="float" id="t0010" orientation="portrait"><label>Table 2</label><caption><p>Summary relevant PBK models for binary, ternary, quaternary, and more complex mixtures.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Reference</th><th colspan="1" rowspan="1">Modeled organism</th><th colspan="1" rowspan="1">Mixture type</th><th colspan="1" rowspan="1">List of chemicals</th><th colspan="1" rowspan="1">Route of administration</th><th colspan="1" rowspan="1">Number of compartments</th><th colspan="1" rowspan="1">Type/Mechanism of interaction</th><th colspan="1" rowspan="1">Basis of interaction</th><th colspan="1" rowspan="1">Basis of PBK model</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><xref rid="b0070" ref-type="bibr">[14]</xref></td><td colspan="1" rowspan="1">Rat and Humans</td><td colspan="1" rowspan="1">Ternary</td><td colspan="1" rowspan="1">Tolune, m-xylene,and ethylbenzene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1"><xref rid="b0125" ref-type="bibr">[25]</xref></td><td colspan="1" rowspan="1"><xref rid="b0120" ref-type="bibr">[24]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0300" ref-type="bibr">[61]</xref></td><td colspan="1" rowspan="1">Human</td><td colspan="1" rowspan="1">Ternary</td><td colspan="1" rowspan="1">Tolune, m-xylene,and ethylbenzene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><xref rid="b0075" ref-type="bibr">[15]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Ternary</td><td colspan="1" rowspan="1">Trichloroethylene, Tetrachloroethylene, Perchloroethylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"><xref rid="b0120" ref-type="bibr">[24]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0305" ref-type="bibr">[62]</xref></td><td colspan="1" rowspan="1">Human</td><td colspan="1" rowspan="1">Ternary</td><td colspan="1" rowspan="1">Tolune, Ethylbenzene, Xylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1"><xref rid="tblfn1" ref-type="table-fn">a</xref>Competitive inhibition</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"><xref rid="b0070" ref-type="bibr">[14]</xref>, <xref rid="b0120" ref-type="bibr">[24]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0310" ref-type="bibr">[63]</xref></td><td colspan="1" rowspan="1">In vitro<xref rid="tblfn10" ref-type="table-fn">b</xref>, <xref rid="tblfn2" ref-type="table-fn">c</xref></td><td colspan="1" rowspan="1">Ternary</td><td colspan="1" rowspan="1">R-Bufuralol, Bunitrolol, Debrisoquine</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">3<xref rid="tblfn3" ref-type="table-fn">d</xref></td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Experiment</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><xref rid="b0080" ref-type="bibr">[16]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Quaternary</td><td colspan="1" rowspan="1">Benezene, Tolune, Ethylbenzene, m-xylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><xref rid="b0085" ref-type="bibr">[17]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Quaternary</td><td colspan="1" rowspan="1">Chloroform, Bromoform, Bromodichloromethane, Dibromochloromethane</td><td colspan="1" rowspan="1">Oral</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">Metabolic inhibition</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><xref rid="b0090" ref-type="bibr">[18]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Quaternary</td><td colspan="1" rowspan="1">Benzene, Toluene, Ethylbenzene, m-xylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"><xref rid="b0080" ref-type="bibr">[16]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0095" ref-type="bibr">[19]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Complex (5+)</td><td colspan="1" rowspan="1">n-hexane, Benzene, Tolune, o-xylene, ethylbenzene, Lump</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"><xref rid="b0115" ref-type="bibr">[23]</xref>, <xref rid="b0140" ref-type="bibr">[28]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0100" ref-type="bibr">[20]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Complex (5+)</td><td colspan="1" rowspan="1">n-hexane, benzene, Tolune, Ethylbenzene, O-xylene, Lumped blend for summer/winter</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"><xref rid="b0115" ref-type="bibr">[23]</xref>, <xref rid="b0140" ref-type="bibr">[28]</xref></td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0160" ref-type="bibr">[32]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Complex (5+)</td><td colspan="1" rowspan="1">n-hexane, Benzene, Tolune, Ethylbenzene, o-xylene, 1/3 cut, 2/3 cut, whole gas</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Competitive inhibiton</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><xref rid="b0110" ref-type="bibr">[22]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Complex</td><td colspan="1" rowspan="1">(n-tetradecane mix, n-octane mix, lumps)</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><xref rid="b0105" ref-type="bibr">[21]</xref></td><td colspan="1" rowspan="1">Rat</td><td colspan="1" rowspan="1">Complex (10+)</td><td colspan="1" rowspan="1">n-pentane, 2-methlpentane, tolune, n-hexane, cyclohexane, benzene, m-xylene, o-xylene</td><td colspan="1" rowspan="1">Inhalation</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">Competitive inhibition</td><td colspan="1" rowspan="1">Simulation</td><td colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>a</label><p id="np005">At high concentration.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn10"><label>b</label><p id="np9000">Microsomal co-incubation.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn2"><label>c</label><p id="np010">Liver PBK model.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn3"><label>d</label><p id="np015">Within the liver.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec id="s0030"><label>4</label><title>Discussion</title><p id="p0080">Various types of mixture PBK models have been developed in the last three decades including models for simultaneous or sequential exposure to two or more defined chemicals involving different species and exposure scenarios. The first PBK model for chemical mixtures was reported to be a type of &#8220;one-chemical mixture&#8221;. The mixture consisted of the parent chemical, benzene, and its metabolites according to Mumtaz et al. <xref rid="b0055" ref-type="bibr">[11]</xref> and Yang and Andersen <xref rid="b0060" ref-type="bibr">[12]</xref>. This was followed by numerous examples of binary mixtures <xref rid="b0060" ref-type="bibr">[12]</xref>, <xref rid="b0065" ref-type="bibr">[13]</xref>, ternary <xref rid="b0070" ref-type="bibr">[14]</xref>, <xref rid="b0075" ref-type="bibr">[15]</xref>, quaternary <xref rid="b0080" ref-type="bibr">[16]</xref>, <xref rid="b0085" ref-type="bibr">[17]</xref>, <xref rid="b0090" ref-type="bibr">[18]</xref>, and complex mixtures <xref rid="b0095" ref-type="bibr">[19]</xref>, <xref rid="b0100" ref-type="bibr">[20]</xref>, <xref rid="b0105" ref-type="bibr">[21]</xref>, <xref rid="b0110" ref-type="bibr">[22]</xref>.</p><p id="p0085">The most common type of PBK model applied for mixtures is based on inhalation of binary combinations of volatile organic compounds investigated in rats <xref rid="b0115" ref-type="bibr">[23]</xref>, <xref rid="b0120" ref-type="bibr">[24]</xref>. More than 60% percent of mixture PBK models in this review involve binary mixture interactions at the toxicokinetic level, i.e., metabolic inhibition <xref rid="b0125" ref-type="bibr">[25]</xref>, <xref rid="b0130" ref-type="bibr">[26]</xref>, <xref rid="b0135" ref-type="bibr">[27]</xref>, <xref rid="b0140" ref-type="bibr">[28]</xref>, <xref rid="b0145" ref-type="bibr">[29]</xref>.</p><p id="p0090">PBK models for binary or higher order mixtures were constructed by first developing models for each chemical separately, and then connecting the individual models via mass balance equations for metabolism in the liver. The equation for the liver was modified to account for various mechanisms of metabolic interaction. In general, three assumptions were used to account for interactions, i.e., competitive inhibition, uncompetitive inhibition, and non-competitive inhibition. The category of interaction was evaluated by observing how well the PBK simulation curve gives an optimal fit after adjusting the hypothesised interaction terms for each chemical.</p><p id="p0095">The interaction in a binary mixture usually occurs via competitive inhibition. The chemical which has the higher concentration in the mixture as a result of either higher dosing or greater blood-air partition coefficient usually acts as an inhibitor compared to the other <xref rid="b0150" ref-type="bibr">[30]</xref>, but inhibition is mostly evident at higher exposure conditions <xref rid="b0130" ref-type="bibr">[26]</xref>, <xref rid="b0150" ref-type="bibr">[30]</xref>. Competitive inhibition was the most common mechanism of interaction during co-exposure of volatile organic compounds probably because most of them are substrates for the same enzyme, CYP 2E1 <xref rid="b0135" ref-type="bibr">[27]</xref>. Competitive types of interaction usually become a concern at higher concentrations compared to environmental or occupational exposure levels <xref rid="b0075" ref-type="bibr">[15]</xref>.</p><p id="p0100">The common mixture PBK modelling approaches fall into two major categories: bottom-up and top-down.</p><sec id="s0035"><label>4.1</label><title>Bottom-up PBK modelling of mixtures</title><p id="p0105">The bottom-up PBK modelling methodology for mixtures is based on one or more interactions at a binary level <xref rid="b0030" ref-type="bibr">[6]</xref>, <xref rid="b0155" ref-type="bibr">[31]</xref>. The possible number of interaction increases as the number of chemicals (N) in a mixture increases by N&#8239;*&#8239;(N&#8239;&#8722;&#8239;1)/2. This approach has been referred as &#8220;bottom-up&#8221; mixture modelling methodology as it involves applying binary interactions to predict complex mixtures <xref rid="b0030" ref-type="bibr">[6]</xref>.</p><p id="p0110">There are numerous examples of the &#8220;bottom-up'' mixture modelling methodology <xref rid="b0060" ref-type="bibr">[12]</xref>, <xref rid="b0065" ref-type="bibr">[13]</xref>. To develop such PBK models, PBK models for each constituent of the mixture first need to be developed and validated. Then linking them together at the binary level (<xref rid="f0020" ref-type="fig">Fig. 4</xref>A) based on the mechanism of interaction should follow, and a network of binary metabolic interactions is created (<xref rid="f0020" ref-type="fig">Fig. 4</xref>B).<fig id="f0020" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>(A) Conceptual representation of a PBK model for a binary mixture of chemicals 1 and 2 that compete with each other for metabolism; (B) A network of binary pharmacokinetic interactions for a mixture of five volatile organic compounds (Toluene (T), m-Xylene (X), Ethylbenzene (E), Dichloromethane (D), Benzene (B)). Figures are .</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr4.jpg"/><attrib>adapted from <xref rid="b0065" ref-type="bibr">[13]</xref>, <xref rid="b0210" ref-type="bibr">[43]</xref></attrib></fig></p><p id="p0115">The bottom-up PBK modelling approach is evident in binary, ternary, quaternary and five chemical mixtures reviewed in this paper. In principle, this methodology should be applicable to any mixture as long as information on each interacting pair is available. However, considering the complex mixtures humans are exposed to, characterising every binary interaction in a mixture is difficult since the number of possible interaction increases by N(N&#8239;&#8722;&#8239;1)/2 as the number of chemicals (N) in a mixture increases <xref rid="b0065" ref-type="bibr">[13]</xref>. Besides, it is impractical or impossible to find data on the increasing number of possible binary combinations in mixtures of increasingly complex compostion. In such cases, a &#8220;top-down&#8221; or lumping approach is more practical where chemicals with similar characteristics are lumped together and described by a central estimate <xref rid="b0030" ref-type="bibr">[6]</xref>, <xref rid="b0095" ref-type="bibr">[19]</xref>.</p></sec><sec id="s0040"><label>4.2</label><title>Top-down PBK modelling of mixtures</title><p id="p0120">Top-down PBK modelling of mixtures is also referred to as lumping. Lumping simplifies complex mixtures to a level where quantitative study of interactions can be successfully implemented using PBK models. This approach is applicable to more complex, multi-component chemical mixtures where characterisation of every possible binary interaction is impractical or unavailable <xref rid="b0030" ref-type="bibr">[6]</xref>, <xref rid="b0095" ref-type="bibr">[19]</xref>, <xref rid="b0160" ref-type="bibr">[32]</xref>. <xref rid="f0025" ref-type="fig">Fig. 5</xref> depicts the approach employed in top-down PBK modelling.<fig id="f0025" position="float" orientation="portrait"><label>Fig. 5</label><caption><p>Flow chart depicting the top-down PBK modelling approach to evaluate interactions in complex gasoline mixtures. The complex gasoline mixture is simplified into &#8216;N&#8217; number of target chemicals and sets of chemical lumps using biologically based lumping methodology as described by Jasper and colleagues <xref rid="b0105" ref-type="bibr">[21]</xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr5.jpg"/></fig></p><p id="p0125">PBK model parameters are employed to lump chemicals in mixtures to enable their description by average parameter values. For example, Dennison et al. <xref rid="b0095" ref-type="bibr">[19]</xref> used this approach to describe the kinetics of a gasoline mixture. The methodology simplifies the problem by isolating target components for which description is required and treating the rest as a single lump chemical. The gasoline mixture was therefore treated as composed of six chemicals with five target chemicals (benzene, toluene, ethylbenzene, <italic toggle="yes">o</italic>-xylenee, n-hexane) and a lumped chemical group representing the whole gasoline mixture (both for the summer and winter blend). Then using a binary interaction methodology for the six chemicals, it was possible to describe the pharmacokinetics of the five target chemicals as well as the lump using a central estimate value.</p><p id="p0130">The individual PBK models for each chemical and the lump were linked by competitive inhibition of hepatic metabolism at a binary level <xref rid="b0095" ref-type="bibr">[19]</xref>, <xref rid="b0160" ref-type="bibr">[32]</xref>. Similarly, Jasper et al. <xref rid="b0105" ref-type="bibr">[21]</xref> have evaluated the role of lumping within the target organ in PBK modelling to describe the toxicokinetics of a complex gasoline mixture following inhalation exposure in rats. A total of 109 chemicals were identified and quantified after inhalation exposure, and the mixture was then simplified to 10 target chemicals and various numbers of lumps. The PBK model simulated well the blood concentration for 10 target chemicals compared to the experimental data when enzymatic interaction was incorporated to the PBK model and by lumping the 99 non target chemicals <xref rid="b0105" ref-type="bibr">[21]</xref>.</p><p id="p0135">Martin et al. <xref rid="b0110" ref-type="bibr">[22]</xref> also used PBK modelling and a lumping approach to give a detailed description of the kinetics of aerosolized and vaporised jet fuel. Their model simulated aromatic and lower molecular weight alkanes more accurately than higher molecular weight alkanes, and showed metabolic interaction to be significant at higher concentrations <xref rid="b0110" ref-type="bibr">[22]</xref>.</p></sec><sec id="s0045"><label>4.3</label><title>PBK modelling of substrate and its inhibitor</title><p id="p0140">In addition to the most common types of PBK models for mixtures based on bottom-up or top-down approaches, PBK models have also been developed to investigate the effect of an inhibitor on substrate metabolism. These substrate and inhibitor combination can be considered as a binary mixture. These PBK models were primarily developed to study the inhibition effect of a chemical on the metabolism of different food additives <xref rid="b0165" ref-type="bibr">[33]</xref>.</p><p id="p0145">A binary PBK model was developed by constructing and validating individual PBK models for both the substrate and inhibitor separately. Then, both models were connected to form a binary PBK model taking into account the type of interaction between the substrate and the inhibitor. The interaction between the inhibitor and substrate is often unidirectional, unlike the conventional PBK models for mixtures where two-way interactions occur among components. For example, Alhusainy and colleagues <xref rid="b0170" ref-type="bibr">[34]</xref> used this approach to investigate the inhibition of estragole by the basil flavonoid nevadensin following oral administration in rats (<xref rid="f0030" ref-type="fig">Fig. 6</xref>).<fig id="f0030" position="float" orientation="portrait"><label>Fig. 6</label><caption><p>Schematic diagram of the PBK model for (A) esragole and (B) nevadensin, as reported in Alhusainy et al. <xref rid="b0170" ref-type="bibr">[34]</xref> and adapted in this figure.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr6.jpg"/></fig></p><p id="p0150">A non-competitive inhibition type of interaction was used to link the PBK model for estragole and nevadensin based on their previous results <xref rid="b0165" ref-type="bibr">[33]</xref>. Similarly, the kinetics and inhibition of safrole and 7-hydroxycoumarin by Mace extract containing malabaricone C was described using PBK models in humans and rats <xref rid="b0175" ref-type="bibr">[35]</xref>.</p><p id="p0155">These PBK models describe kinetic interactions in various organs (liver, lung and kidney) and involve various enzymes and phases of metabolism <xref rid="b0165" ref-type="bibr">[33]</xref>, <xref rid="b0170" ref-type="bibr">[34]</xref>, <xref rid="b0175" ref-type="bibr">[35]</xref> unlike conventional PBK models that are limited to metabolism in the liver by a single enzyme. However, these models are of limited applicability since their original purpose was to investigate inhibition in alkenylbenzene food additives. However, the concepts and assumptions used in these models could be applied to conventional PBK models to widen their applicability and relevance.</p></sec><sec id="s0050"><label>4.4</label><title>Interactions in mixtures</title><sec id="s0055"><label>4.4.1</label><title>Types of interactions</title><p id="p0160">Exposure to mixtures can lead to combined effects, toxicokinetic and toxicodynamic interactions. The majority of interactions in mixtures occur during the toxicokinetic phase <xref rid="b0180" ref-type="bibr">[36]</xref>. Toxicokinetic interactions affect the concentration of chemicals reaching the target site, thereby modifying the response or toxicity compared to that predicted using dose addition, and making the mixture risk assessment more challenging <xref rid="b0030" ref-type="bibr">[6]</xref>.</p><p id="p0165">The most common type or mechanism of interaction among the mixture PBK models reviewed was competitive inhibition. In most of the cases, PBK modelling simulations investigated interactions by comparing the observed kinetics of the mixtures with the kinetics predicted by the model containing various scenarios for the type of inhibition (see <xref rid="t0015" ref-type="table">Table 3</xref>).<table-wrap position="float" id="t0015" orientation="portrait"><label>Table 3</label><caption><p>Types of inhibition and their corresponding equations used for PBK modelling of a ternary mixture.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Hypothesis tested for interaction in ternary mixture</th><th colspan="1" rowspan="1">Chemical 1</th><th colspan="1" rowspan="1">Chemical 2</th><th colspan="1" rowspan="1">Chemical 3</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Equation for rate of metabolism (RAM) for Competitive inhibition</td><td colspan="1" rowspan="1"><inline-formula><mml:math id="M1" altimg="si1.gif" overflow="scroll"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Vmax</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Km</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:math></inline-formula></td><td colspan="1" rowspan="1"><inline-formula><mml:math id="M2" altimg="si2.gif" overflow="scroll"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Vmax</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Km</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:math></inline-formula></td><td colspan="1" rowspan="1"><inline-formula><mml:math id="M3" altimg="si3.gif" overflow="scroll"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Vmax</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Km</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:math></inline-formula></td></tr><tr><td colspan="1" rowspan="1">Equation for RAM for Uncompetitive inhibition</td><td colspan="1" rowspan="1"><inline-formula><mml:math id="M4" altimg="si4.gif" overflow="scroll"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Vmax</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Km</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:math></inline-formula></td><td colspan="1" rowspan="1"><inline-formula><mml:math id="M5" altimg="si5.gif" overflow="scroll"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Vmax</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Km</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:math></inline-formula></td><td colspan="1" rowspan="1"><inline-formula><mml:math id="M6" altimg="si6.gif" overflow="scroll"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Vmax</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">Km</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mo>&#8727;</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mi mathvariant="italic">CV</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">Ki</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:math></inline-formula></td></tr></tbody></table></table-wrap></p><p id="p0170">Results from previous experimental studies were also used in some instances to determine the type of interaction <xref rid="b0185" ref-type="bibr">[37]</xref>. Sometimes, an experimental study and PBK modelling are combined to validate the type of interactions existing in a mixture <xref rid="b0190" ref-type="bibr">[38]</xref> or to investigate the mechanism of an inhibitor on various substrates <xref rid="b0165" ref-type="bibr">[33]</xref>, <xref rid="b0175" ref-type="bibr">[35]</xref>. The fact that most chemicals in the investigated mixtures were substrates for a single or specific enzyme was also used to support the hypothesis that most of the interactions in mixtures are competitive in nature <xref rid="b0135" ref-type="bibr">[27]</xref>.</p></sec><sec id="s0060"><label>4.4.2</label><title>Consequences of interactions</title><p id="p0175">Interactions at the level of toxicokinetics (absorption, distribution, metabolism, excretion) of chemicals affect the concentration reaching the target site, and thereby result in a reduced or increased response/toxicity. Competitive inhibition decreases metabolism of the parent compound, which leads to increased toxicity if the parent compound is more toxic, and reduced toxicity if the toxicity results from the metabolite (<xref rid="f0035" ref-type="fig">Fig. 7</xref>).<fig id="f0035" position="float" orientation="portrait"><label>Fig. 7</label><caption><p>Consequence of inhibition on toxicity depending on whether the parent compound or metabolite is toxic.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr7.jpg"/></fig></p><p id="p0180">Some examples of the consequences of toxicokinetic and toxicodynamic interactions are given in <xref rid="t0020" ref-type="table">Table 4</xref>. The inhibitor is usually the one with the higher concentration, e.g., trichloroethylene is a more effective inhibitor in a binary mixture of vinyl chloride and trichloroethylene co-exposure. The relatively higher concentration of trichloroethylene compared to vinyl chloride even in a similar exposure situation is attributed to a larger blood-air partition coefficient for trichloroethylene which leads to an increased concentration in blood <xref rid="b0150" ref-type="bibr">[30]</xref>. However, it is also important to note that competitive types of interactions usually become a concern only at higher concentrations than environmental or occupational exposure levels <xref rid="b0075" ref-type="bibr">[15]</xref>.<table-wrap position="float" id="t0020" orientation="portrait"><label>Table 4</label><caption><p>Examples of the consequences of toxicokinetic and toxicodynamic interactions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Mixtures</th><th colspan="2" rowspan="1">Toxicokinetic interaction<hr/></th><th colspan="2" rowspan="1">Toxicodynamic interaction<hr/></th><th colspan="1" rowspan="1">References<hr/></th></tr><tr><th colspan="1" rowspan="1">Reduced concentration of metabolite</th><th colspan="1" rowspan="1">Increased target concentration of substrate</th><th colspan="1" rowspan="1">Reduced toxicity from metabolite</th><th colspan="1" rowspan="1">Increased toxicity from parent chemicals</th><th colspan="1" rowspan="1"/></tr></thead><tbody><tr><td colspan="1" rowspan="1">Vinyl chloride and Trichloroethylene</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Vinyl chloride</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Significant neurobehavioural effect in workers within TLV</td><td colspan="1" rowspan="1"><xref rid="b0150" ref-type="bibr">[30]</xref>, <xref rid="b0315" ref-type="bibr">[64]</xref></td></tr><tr><td colspan="1" rowspan="1">Toluene and Trichloroethylene</td><td colspan="1" rowspan="1">Hippuric acid</td><td colspan="1" rowspan="1">Toluene</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b0190" ref-type="bibr">[38]</xref></td></tr><tr><td colspan="1" rowspan="1">Benzene and Toluene</td><td colspan="1" rowspan="1">Phenol and hippuric acid</td><td colspan="1" rowspan="1">Benzene</td><td colspan="1" rowspan="1">Leukopenia or other toxicities from metabolite of benzene</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b0140" ref-type="bibr">[28]</xref>, <xref rid="b0320" ref-type="bibr">[65]</xref>, <xref rid="b0325" ref-type="bibr">[66]</xref>, <xref rid="b0330" ref-type="bibr">[67]</xref></td></tr><tr><td colspan="1" rowspan="1">Toluene and m-xylene</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Toluene</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b0130" ref-type="bibr">[26]</xref></td></tr><tr><td colspan="1" rowspan="1">Trichloroethylene and Tetrachloroethylene</td><td colspan="1" rowspan="1">metabolite of Trichloroethylene</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b0075" ref-type="bibr">[15]</xref></td></tr><tr><td colspan="1" rowspan="1">Trichloroethylene and 1,1-dichloroethylene</td><td colspan="1" rowspan="1">Metabolite of 1,1-dichloroethylene</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Reduced 1,1-dichloroethylene hepatotoxicity</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><xref rid="b0125" ref-type="bibr">[25]</xref></td></tr></tbody></table></table-wrap></p></sec><sec id="s0065"><label>4.4.3</label><title>Relevance of interactions</title><p id="p0185">Evidence in the literature indicates that interactions occur in chemical mixtures, but are observed mainly at higher exposure concentrations. Boobis et al. <xref rid="b0195" ref-type="bibr">[39]</xref> performed a literature review, identifying 90 studies demonstrating synergisms in mammalian test systems performed at low doses (i.e. close to the point of departure, POD) for individual chemicals. Only 6 of the 90 studies reported useful quantitative information on the magnitude of synergy. In those six studies the difference between observed synergisms and predictions by CA did not deviate by more than a factor of 4. Cedergreen <xref rid="b0200" ref-type="bibr">[40]</xref> performed a systematic literature review for binary mixtures within three groups of environmentally relevant chemicals (pesticides, metals, antifouling agents). Synergy was defined as a minimum two-fold deviation from CA predictions. Synergy was found in 7%, 3% and 26% of the pesticide, metal and antifoulant mixtures, respectively. The extent of synergy was rarely more than a factor of 10. Based on an in-depth analysis, Cedergreen concluded that true synergistic interactions between chemicals are rare and often occur at high concentrations. Using standard models such as CA is regarded as the most important step in the risk assessment of chemical mixtures.</p><p id="p0190">Our review of PBK models confirmed that interactions mainly occurred at concentrations higher than common environmental or occupational exposure levels. However, there are examples where interactions might be relevant to consider, such as in the context of food safety (reviewed by <xref rid="b9005" ref-type="bibr">[41]</xref>).</p></sec></sec><sec id="s0070"><label>4.5</label><title>Challenges and opportunities for PBK modelling of mixtures</title><p id="p0195">One of the major challenges of PBK modelling is the requirement for a large amount of data to build the model. This challenge is even more obvious in mixture PBK modelling since there are more chemicals and interactions to consider in addition to the vast amounts of data for physicochemical and biochemical parameters. A solution to this challenge can be the application of quantitative structure activity relationship (QSAR) modelling. <xref rid="t0025" ref-type="table">Table 5</xref> shows examples of the chemical kinetic parameters determined using QSAR modelling. Another challenge is the need for trained specialists to develop and validate the models. However, PBK modelling also has several advantages and could support risk assessment of mixtures since it can account for interactions in a mixture. PBK modelling of mixtures may be relevant in addressing risks from co-exposure of both humans and environmental organisms to multiple chemicals in integrated mixture hazard and risk assessments <xref rid="b0205" ref-type="bibr">[42]</xref>.<table-wrap position="float" id="t0025" orientation="portrait"><label>Table 5</label><caption><p>Some of the QSAR models used to determine toxicokinetics parameters for PBK modelling.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Reference</th><th colspan="1" rowspan="1">Toxicokinetics</th><th colspan="1" rowspan="1">Parameters predicted</th><th colspan="1" rowspan="1">Objective/Target compounds</th><th colspan="1" rowspan="1">QSAR modelling Method employed</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><xref rid="b0335" ref-type="bibr">[68]</xref></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Modelling of CYP 450 metabolism of chlorinated organic volatile compounds</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><xref rid="b0340" ref-type="bibr">[69]</xref></td><td colspan="1" rowspan="1">Metabolism</td><td colspan="1" rowspan="1">Vmax/Km</td><td colspan="1" rowspan="1">Organophosphorus compounds</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><xref rid="b0345" ref-type="bibr">[70]</xref></td><td colspan="1" rowspan="1">Metabolism</td><td colspan="1" rowspan="1">Km</td><td colspan="1" rowspan="1">59 substrates of CYP 3A4</td><td colspan="1" rowspan="1">e-state descriptors</td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0350" ref-type="bibr">[71]</xref></td><td colspan="1" rowspan="1">Metabolism</td><td colspan="1" rowspan="1">Km (app)</td><td colspan="1" rowspan="1">CYP 3A4 inhibitors</td><td colspan="1" rowspan="1">Pharmacophore modelling</td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0355" ref-type="bibr">[72]</xref></td><td colspan="1" rowspan="1">Absorption, Elimination</td><td colspan="1" rowspan="1">P, Clint, CLh</td><td colspan="1" rowspan="1">Volatile compounds</td><td colspan="1" rowspan="1">Group combination method</td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0360" ref-type="bibr">[73]</xref></td><td colspan="1" rowspan="1">TD</td><td colspan="1" rowspan="1">Toxicity</td><td colspan="1" rowspan="1">53 Volatile Organic Compounds</td><td colspan="1" rowspan="1">Group combination method</td></tr><tr><td colspan="1" rowspan="1"><xref rid="b0365" ref-type="bibr">[74]</xref></td><td colspan="1" rowspan="1">Metabolism</td><td colspan="1" rowspan="1">Km/Vmax</td><td colspan="1" rowspan="1">VOCs</td><td colspan="1" rowspan="1">Group contribution method</td></tr></tbody></table></table-wrap></p><p id="p0200">Both bottom-up and top-down of PBK modelling approaches are based on binary interactions of parent chemicals whereas in reality interactions could occur between the parent and metabolite, as well as between metabolites. The models assume binary interactions, while in a reality humans are exposed to two or more chemicals at the same time, which is a more complex situation. Published models of mixtures of greater complexity are derived from information on binary interactions to simulate the interactions between all mixture components simultaneously.</p><p id="p0205">Conventional types of PBK modelling can benefit from incorporation of relevant physiological processes. For example, metabolism by a single enzyme is assumed in the conventional bottom-up and top-down PBK modelling approaches for mixtures. However, usually there are different <italic toggle="yes">iso</italic>-enzymes and enzymes metabolising chemicals during phase 1 and phase 2 biotransformation. Moreover, in most of the PBK models reviewed the assumption was that metabolism and interactions occurred mainly in the liver. Even though on one hand such assumptions are important to simplify the model, on the other hand this is also limiting information, since other key organs could play a role in the mode of action of mixtures. Furthermore, relevant interactions in the absorption, distribution, metabolism and clearance phases should at least be added for some relevant chemicals to make the mixture PBK models more relevant and applicable in the future.</p><p id="p0210">Capturing mixture interactions in the development of PBK model platforms (freely available tools, such as, MeGEN, COSMOS-KNIME, IndusChemFate, PLETHEM, R-httk) is another challenge. To our knowledge the above-mentioned platforms do not take into consideration environmental chemical co-exposure and mixture interactions, although some commercial platforms such as SimCyp and Gastroplus address drug to drug interactions.</p></sec></sec><sec id="s0075"><label>5</label><title>Conclusions</title><p id="p0215">PBK modelling can support the risk assessment of mixtures by including information on kinetics and ADME, thus describing the mechanisms of interaction occurring in mixtures. The risk assessment of mixtures currently relies mostly on concentration addition based approaches, thus neglecting possible interactions. We lay down two approaches that could be implemented in several PBK model software and packages. These approaches, are termed bottom-up and top-down, depending on whether the interactions are described in terms of a series of binary interactions, or by lumping mixture components and using representative parameter values. The choice of approach depends on the complexity of the mixture and availability of binary interaction data. These PBK modelling approaches should be further investigated for their applicability in mixture risk assessment.</p></sec></body><back><ref-list id="bi005"><title>References</title><ref id="b0005"><label>1</label><element-citation publication-type="journal" id="h0005"><person-group person-group-type="author"><name name-style="western"><surname>Kienzler</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bopp</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Van Der Linden</surname><given-names>S.</given-names></name><name name-style="western"><surname>Berggren</surname><given-names>E.</given-names></name><name name-style="western"><surname>Worth</surname><given-names>A.</given-names></name></person-group><article-title>Regulatory assessment of chemical mixtures: requirements, current approaches and future perspectives</article-title><source>Regul. Toxicol. Pharm.</source><volume>80</volume><year>2016</year><fpage>321</fpage><lpage>334</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yrtph.2016.05.020</pub-id><pub-id pub-id-type="pmid">27211294</pub-id></element-citation></ref><ref id="b0010"><label>2</label><element-citation publication-type="book" id="h0010"><person-group person-group-type="author"><name name-style="western"><surname>Bjarnason</surname><given-names>S.G.</given-names></name></person-group><chapter-title>Toxicology of Chemical Mixtures: A Review of Mixtures Assessment</chapter-title><year>2004</year><publisher-name>DTIC Document</publisher-name></element-citation></ref><ref id="b0015"><label>3</label><mixed-citation publication-type="other" id="h0015">S. Bopp, E. Berggren, A Kienzler, S. van der Linden, A Worth, 2015. Scientific methodologies for the combined effects of chemicals &#8211; a survey and literature review; EUR 27471 EN; doi: 10.2788/093511.</mixed-citation></ref><ref id="b0020"><label>4</label><mixed-citation publication-type="other" id="h0020">SCHER SCCS SCENIHR 2012. Opinion on the Toxicity and Assessment of Chemical Mixtures.</mixed-citation></ref><ref id="b0025"><label>5</label><element-citation publication-type="journal" id="h0025"><person-group person-group-type="author"><name name-style="western"><surname>Heys</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Shore</surname><given-names>R.F.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>F.L.</given-names></name></person-group><article-title>Risk assessment of environmental mixture effects</article-title><source>RSC Adv.</source><year>2016</year><fpage>47844</fpage><lpage>47857</lpage></element-citation></ref><ref id="b0030"><label>6</label><element-citation publication-type="journal" id="h0030"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>Y.-M.</given-names></name><name name-style="western"><surname>Clewell</surname><given-names>H.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>J.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.</given-names></name></person-group><article-title>Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment</article-title><source>Int. J. Environ. Res. Public Health</source><volume>8</volume><year>2011</year><fpage>1613</fpage><lpage>1630</lpage><pub-id pub-id-type="pmid">21655141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijerph8051613</pub-id><pub-id pub-id-type="pmcid">PMC3108131</pub-id></element-citation></ref><ref id="b0035"><label>7</label><mixed-citation publication-type="other" id="h0035">EPA 2007. Approaches for the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data in Risk Assessment (Final Report). In: ASSESSMENT, N. C. F. E. (ed.). Washington, DC: U.S. Environmental Protection Agency.</mixed-citation></ref><ref id="b0040"><label>8</label><element-citation publication-type="book" id="h0040"><person-group person-group-type="author"><name name-style="western"><surname>Johanson</surname><given-names>G.</given-names></name></person-group><chapter-title>Modeling of disposition</chapter-title><person-group person-group-type="editor"><name name-style="western"><surname>Mcqueen</surname><given-names>Charlene A.</given-names></name></person-group><source>Comprehensive Toxicology</source><edition>second Ed.</edition><year>2010</year><publisher-name>Elsevier Ltd</publisher-name><publisher-loc>Oxford</publisher-loc></element-citation></ref><ref id="b0045"><label>9</label><mixed-citation publication-type="other" id="h0045">Who, Characterization and application of physiologically based pharmacokinetic models in risk assessment Harmonization Project Document 2010 9.</mixed-citation></ref><ref id="b0050"><label>10</label><element-citation publication-type="journal" id="h0050"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Goldsmith</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Grulke</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>D.T.</given-names></name><name name-style="western"><surname>Brooks</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Hypes</surname><given-names>E.D.</given-names></name><name name-style="western"><surname>Fair</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Tornero-Velez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dary</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y.M.</given-names></name></person-group><article-title>Developing a physiologically-based pharmacokinetic model knowledgebase in support of provisional model construction</article-title><source>PLoS Comput. Biol.</source><volume>12</volume><year>2016</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pcbi.1004495</pub-id><pub-id pub-id-type="pmcid">PMC4752336</pub-id><pub-id pub-id-type="pmid">26871706</pub-id></element-citation></ref><ref id="b0055"><label>11</label><element-citation publication-type="journal" id="h0055"><person-group person-group-type="author"><name name-style="western"><surname>Mumtaz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sipes</surname><given-names>I.</given-names></name><name name-style="western"><surname>Clewell</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.</given-names></name></person-group><article-title>Risk assessment of chemical mixtures: biologic and toxicologic issues</article-title><source>Fundam. Appl. Toxicol.</source><volume>21</volume><year>1993</year><fpage>258</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">8258379</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/faat.1993.1098</pub-id></element-citation></ref><ref id="b0060"><label>12</label><element-citation publication-type="book" id="h0060"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>R.S.H.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name></person-group><chapter-title>Mixtures</chapter-title><person-group person-group-type="editor"><name name-style="western"><surname>Reddy</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.S.H.</given-names></name><name name-style="western"><surname>Clewell</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name></person-group><source>Physiologically Based Pharmacokinetic Modeling</source><year>2005</year><publisher-name>John Wiley &amp; Sons, Inc</publisher-name><publisher-loc>Hoboken, NJ USA</publisher-loc></element-citation></ref><ref id="b0065"><label>13</label><element-citation publication-type="book" id="h0065"><person-group person-group-type="author"><name name-style="western"><surname>Haddad</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>J.</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name></person-group><chapter-title>Physiologically Based Modeling of Pharmacokinetic Interactions in Chemical Mixtures</chapter-title><year>2010</year><publisher-name>John Wiley &amp; Sons Ltd</publisher-name><publisher-loc>Quantitative Modeling in Toxicology</publisher-loc></element-citation></ref><ref id="b0070"><label>14</label><element-citation publication-type="journal" id="h0070"><person-group person-group-type="author"><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name><name name-style="western"><surname>Charest-Tardif</surname><given-names>G.</given-names></name><name name-style="western"><surname>Brodeur</surname><given-names>J.</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name></person-group><article-title>Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>144</volume><year>1997</year><fpage>120</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">9169076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1996.8096</pub-id></element-citation></ref><ref id="b0075"><label>15</label><element-citation publication-type="journal" id="h0075"><person-group person-group-type="author"><name name-style="western"><surname>Dobrev</surname><given-names>I.D.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.S.H.</given-names></name></person-group><article-title>Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling</article-title><source>Arch. Toxicol.</source><volume>75</volume><year>2001</year><fpage>134</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">11409535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002040100216</pub-id></element-citation></ref><ref id="b0080"><label>16</label><element-citation publication-type="journal" id="h0080"><person-group person-group-type="author"><name name-style="western"><surname>Haddad</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name><name name-style="western"><surname>Charest-Tardif</surname><given-names>G.</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name></person-group><article-title>Physiological Modeling of the Toxicokinetic Interactions in a Quaternary Mixture of Aromatic Hydrocarbons</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>161</volume><year>1999</year><fpage>249</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">10620482</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1999.8803</pub-id></element-citation></ref><ref id="b0085"><label>17</label><element-citation publication-type="journal" id="h0085"><person-group person-group-type="author"><name name-style="western"><surname>Luciene Da Silva</surname><given-names>M.</given-names></name><name name-style="western"><surname>Charest-Tardif</surname><given-names>G.</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name></person-group><article-title>Influence of oral administration of a quaternary mixture of trihalomethanes on their blood kinetics in the rat</article-title><source>Toxicol. Lett.</source><volume>106</volume><year>1999</year><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">10378450</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-4274(99)00022-3</pub-id></element-citation></ref><ref id="b0090"><label>18</label><element-citation publication-type="journal" id="h0090"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bois</surname><given-names>F.Y.</given-names></name></person-group><article-title>A mechanistic modeling framework for predicting metabolic interactions in complex mixtures</article-title><source>Environ. Health Perspect.</source><volume>119</volume><year>2011</year><fpage>1712</fpage><lpage>1718</lpage><pub-id pub-id-type="pmid">21835728</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.1103510</pub-id><pub-id pub-id-type="pmcid">PMC3261979</pub-id></element-citation></ref><ref id="b0095"><label>19</label><element-citation publication-type="journal" id="h0095"><person-group person-group-type="author"><name name-style="western"><surname>Dennison</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.S.H.</given-names></name></person-group><article-title>Characterization of the pharmacokinetics of gasoline using PBPK modeling with a complex mixtures chemical lumping approach</article-title><source>Inhalation Toxicol.</source><volume>15</volume><year>2003</year><fpage>961</fpage><lpage>986</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08958370390215749</pub-id><pub-id pub-id-type="pmid">12928975</pub-id></element-citation></ref><ref id="b0100"><label>20</label><element-citation publication-type="journal" id="h0100"><person-group person-group-type="author"><name name-style="western"><surname>Dennison</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Dobrev</surname><given-names>I.D.</given-names></name><name name-style="western"><surname>Mumtaz</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.S.H.</given-names></name></person-group><article-title>Pbpk modeling of complex hydrocarbon mixtures: Gasoline</article-title><source>Environ. Toxicol. Pharmacol.</source><volume>16</volume><year>2004</year><fpage>107</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">21782697</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.etap.2003.10.003</pub-id></element-citation></ref><ref id="b0105"><label>21</label><element-citation publication-type="journal" id="h0105"><person-group person-group-type="author"><name name-style="western"><surname>Jasper</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Oshiro</surname><given-names>W.M.</given-names></name><name name-style="western"><surname>Ford</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bushnell</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>El-Masri</surname><given-names>H.</given-names></name></person-group><article-title>Application of biologically based lumping to investigate the toxicokinetic interactions of a complex gasoline mixture</article-title><source>Environ. Sci. Technol.</source><volume>50</volume><year>2016</year><fpage>3231</fpage><lpage>3238</lpage><pub-id pub-id-type="pmid">26889718</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.est.5b05648</pub-id></element-citation></ref><ref id="b0110"><label>22</label><element-citation publication-type="journal" id="h0110"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Tremblay</surname><given-names>R.T.</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>J.W.</given-names></name></person-group><article-title>Development of a physiologically based pharmacokinetic model for inhalation of jet fuels in the rat</article-title><source>Inhalation Toxicol.</source><volume>24</volume><year>2012</year><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/08958378.2011.631297</pub-id><pub-id pub-id-type="pmid">22188408</pub-id></element-citation></ref><ref id="b0115"><label>23</label><element-citation publication-type="journal" id="h0115"><person-group person-group-type="author"><name name-style="western"><surname>Gargas</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Clewell</surname><given-names>H.J.</given-names></name></person-group><article-title>A physiologically based simulation approach for determining metabolic constants from gas uptake data</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>86</volume><year>1986</year><fpage>341</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">3787629</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0041-008x(86)90361-3</pub-id></element-citation></ref><ref id="b0120"><label>24</label><element-citation publication-type="journal" id="h0120"><person-group person-group-type="author"><name name-style="western"><surname>Ramsey</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name></person-group><article-title>A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>73</volume><year>1984</year><fpage>159</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">6710512</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0041-008x(84)90064-4</pub-id></element-citation></ref><ref id="b0125"><label>25</label><element-citation publication-type="journal" id="h0125"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Gargas</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Clewell</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Severyn</surname><given-names>K.M.</given-names></name></person-group><article-title>Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>89</volume><year>1987</year><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">3603553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0041-008x(87)90035-4</pub-id></element-citation></ref><ref id="b0130"><label>26</label><element-citation publication-type="journal" id="h0130"><person-group person-group-type="author"><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lapare</surname><given-names>S.</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Brodeur</surname><given-names>J.</given-names></name></person-group><article-title>Physiologically based modeling of the toxicokinetic interaction between toluene and m-xylene in the rat</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>120</volume><year>1993</year><fpage>266</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">8511796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1993.1111</pub-id></element-citation></ref><ref id="b0135"><label>27</label><element-citation publication-type="journal" id="h0135"><person-group person-group-type="author"><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pelekis</surname><given-names>M.</given-names></name></person-group><article-title>Hematotoxic interactions: occurrence, mechanisms and predictability</article-title><source>Toxicology</source><volume>105</volume><year>1995</year><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">8571372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0300-483x(96)83476-7</pub-id></element-citation></ref><ref id="b0140"><label>28</label><element-citation publication-type="journal" id="h0140"><person-group person-group-type="author"><name name-style="western"><surname>Purcell</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Cason</surname><given-names>G.H.</given-names></name><name name-style="western"><surname>Gargas</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Travis</surname><given-names>C.C.</given-names></name></person-group><article-title>In vivo metabolic interactions of benzene and toluene</article-title><source>Toxicol. Lett.</source><volume>52</volume><year>1990</year><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">2377998</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-4274(90)90148-f</pub-id></element-citation></ref><ref id="b0145"><label>29</label><element-citation publication-type="journal" id="h0145"><person-group person-group-type="author"><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lapare</surname><given-names>S.</given-names></name><name name-style="western"><surname>Charest-Tardif</surname><given-names>G.</given-names></name><name name-style="western"><surname>Brodeur</surname><given-names>J.</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name></person-group><article-title>Physiologically-based pharmacokinetic modeling of a mixture of toluene and xylene in humans</article-title><source>Risk Anal.</source><volume>15</volume><year>1995</year><fpage>335</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">7604167</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1539-6924.1995.tb00326.x</pub-id></element-citation></ref><ref id="b0150"><label>30</label><element-citation publication-type="journal" id="h0150"><person-group person-group-type="author"><name name-style="western"><surname>Barton</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Creech</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Godin</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Randall</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Seckel</surname><given-names>C.S.</given-names></name></person-group><article-title>Chloroethylene mixtures: pharmacokinetic modeling and in vitro metabolism of vinyl chloride, trichloroethylene, and trans-1,2-Dichloroethylene in Rat</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>130</volume><year>1995</year><fpage>237</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">7871537</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1995.1029</pub-id></element-citation></ref><ref id="b0155"><label>31</label><element-citation publication-type="journal" id="h0155"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>R.S.H.</given-names></name><name name-style="western"><surname>El-Masri</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Constan</surname><given-names>A.A.</given-names></name></person-group><article-title>The use of physiologically-based pharmacokinetic/ pharmacodynamic dosimetry models for chemical mixtures</article-title><source>Toxicol. Lett.</source><volume>82</volume><year>1995</year><fpage>497</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">8597101</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-4274(95)03579-6</pub-id></element-citation></ref><ref id="b0160"><label>32</label><element-citation publication-type="journal" id="h0160"><person-group person-group-type="author"><name name-style="western"><surname>Dennison</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Clewell</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.S.H.</given-names></name></person-group><article-title>Development of a physiologically based pharmacokinetic model for volatile fractions of gasoline using chemical lumping analysis</article-title><source>Environ. Sci. Technol.</source><volume>38</volume><year>2004</year><fpage>5674</fpage><lpage>5681</lpage><pub-id pub-id-type="pmid">15575287</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/es035201s</pub-id></element-citation></ref><ref id="b0165"><label>33</label><element-citation publication-type="journal" id="h0165"><person-group person-group-type="author"><name name-style="western"><surname>Alhusainy</surname><given-names>W.</given-names></name><name name-style="western"><surname>Paini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Punt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Louisse</surname><given-names>J.</given-names></name><name name-style="western"><surname>Spenkelink</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vervoort</surname><given-names>J.</given-names></name><name name-style="western"><surname>Delatour</surname><given-names>T.</given-names></name><name name-style="western"><surname>Scholz</surname><given-names>G.</given-names></name><name name-style="western"><surname>Schilter</surname><given-names>B.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>T.</given-names></name><name name-style="western"><surname>Van Bladeren</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Rietjens</surname><given-names>I.M.C.M.</given-names></name></person-group><article-title>Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>245</volume><year>2010</year><fpage>179</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">20226806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2010.02.017</pub-id></element-citation></ref><ref id="b0170"><label>34</label><element-citation publication-type="journal" id="h0170"><person-group person-group-type="author"><name name-style="western"><surname>Alhusainy</surname><given-names>W.</given-names></name><name name-style="western"><surname>Paini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Berg</surname><given-names>J.H.J.V.D.</given-names></name><name name-style="western"><surname>Punt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scholz</surname><given-names>G.</given-names></name><name name-style="western"><surname>Schilter</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bladeren</surname><given-names>P.J.V.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>S.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Rietjens</surname><given-names>I.M.C.M.</given-names></name></person-group><article-title>In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin</article-title><source>Mol. Nutr. Food Res.</source><volume>57</volume><year>2013</year><fpage>1969</fpage><lpage>1978</lpage><pub-id pub-id-type="pmid">23894034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mnfr.201300144</pub-id></element-citation></ref><ref id="b0175"><label>35</label><element-citation publication-type="journal" id="h0175"><person-group person-group-type="author"><name name-style="western"><surname>Martati</surname><given-names>E.</given-names></name><name name-style="western"><surname>Boonpawa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Van Den Berg</surname><given-names>J.H.J.</given-names></name><name name-style="western"><surname>Paini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Spenkelink</surname><given-names>A.</given-names></name><name name-style="western"><surname>Punt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vervoort</surname><given-names>J.</given-names></name><name name-style="western"><surname>Van Bladeren</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Rietjens</surname><given-names>I.M.C.M.</given-names></name></person-group><article-title>Malabaricone C-containing mace extract inhibits safrole bioactivation and DNA adduct formation both in vitro and in vivo</article-title><source>Food Chem. Toxicol.</source><volume>66</volume><year>2014</year><fpage>373</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">24508526</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fct.2014.01.043</pub-id></element-citation></ref><ref id="b0180"><label>36</label><element-citation publication-type="journal" id="h0180"><person-group person-group-type="author"><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Brodeur</surname><given-names>J.</given-names></name></person-group><article-title>Toxicological consequences of combined exposure to environmental pollutants</article-title><source>Arch. Complex Environ. Stud.</source><volume>3</volume><year>1991</year><fpage>1</fpage><lpage>106</lpage></element-citation></ref><ref id="b0185"><label>37</label><element-citation publication-type="journal" id="h0185"><person-group person-group-type="author"><name name-style="western"><surname>Pankow</surname><given-names>D.</given-names></name><name name-style="western"><surname>Matschiner</surname><given-names>F.</given-names></name><name name-style="western"><surname>Weigmann</surname><given-names>H.-J.</given-names></name></person-group><article-title>Influence of aromatic hydrocarbons on the metabolism of dichloromethane to carbon monoxide in rats</article-title><source>Toxicology</source><volume>68</volume><year>1991</year><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">1871779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0300-483x(91)90064-8</pub-id></element-citation></ref><ref id="b0190"><label>38</label><element-citation publication-type="journal" id="h0190"><person-group person-group-type="author"><name name-style="western"><surname>Thrall</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Poet</surname><given-names>T.S.</given-names></name></person-group><article-title>Determination of biokinetic interactions in chemical mixtures using real-time breath analysis and physiologically based pharmacokinetic modeling</article-title><source>J. Toxicol. Environ. Health Part A</source><volume>598</volume><year>2000</year><fpage>1528</fpage><lpage>7394</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/009841000156646</pub-id><pub-id pub-id-type="pmid">10839498</pub-id></element-citation></ref><ref id="b0195"><label>39</label><element-citation publication-type="journal" id="h0195"><person-group person-group-type="author"><name name-style="western"><surname>Boobis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Budinsky</surname><given-names>R.</given-names></name><name name-style="western"><surname>Collie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Crofton</surname><given-names>K.</given-names></name><name name-style="western"><surname>Embry</surname><given-names>M.</given-names></name><name name-style="western"><surname>Felter</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hertzberg</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kopp</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mihlan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mumtaz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Price</surname><given-names>P.</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>K.</given-names></name><name name-style="western"><surname>Teuschler</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zaleski</surname><given-names>R.</given-names></name></person-group><article-title>Critical analysis of literature on low-dose synergy for use in screening chemical mixtures for risk assessment</article-title><source>Crit. Rev. Toxicol.</source><volume>41</volume><year>2011</year><fpage>369</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">21309635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/10408444.2010.543655</pub-id></element-citation></ref><ref id="b0200"><label>40</label><element-citation publication-type="journal" id="h0200"><person-group person-group-type="author"><name name-style="western"><surname>Cedergreen</surname><given-names>N.</given-names></name></person-group><article-title>Quantifying synergy: a systematic review of mixture toxicity studies within environmental toxicology</article-title><source>PLoS ONE</source><year>2014</year><fpage>9</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0096580</pub-id><pub-id pub-id-type="pmcid">PMC4008607</pub-id><pub-id pub-id-type="pmid">24794244</pub-id></element-citation></ref><ref id="b9005"><label>41</label><element-citation publication-type="journal" id="h9005"><person-group person-group-type="author"><name name-style="western"><surname>Quignot</surname><given-names>N.</given-names></name><name name-style="western"><surname>B&#233;chaux</surname><given-names>C.</given-names></name><name name-style="western"><surname>Amzal</surname><given-names>B.</given-names></name></person-group><article-title>Data collection on toxicokinetic and toxicodynamic interactions of chemical mixtures for human risk assessment</article-title><source>EFSA Supporting Publications</source><volume>12</volume><year>2015</year><fpage>711E</fpage></element-citation></ref><ref id="b0205"><label>42</label><element-citation publication-type="journal" id="h0205"><person-group person-group-type="author"><name name-style="western"><surname>P&#233;ry</surname><given-names>A.R.R.G.</given-names></name><name name-style="western"><surname>Sch&#252;&#252;rmannb</surname><given-names>Ciffroy P.</given-names></name><name name-style="western"><surname>Fauste</surname><given-names>C.</given-names></name><name name-style="western"><surname>Backhause</surname><given-names>T.</given-names></name><name name-style="western"><surname>Aicher</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mombelli</surname><given-names>E.</given-names></name><name name-style="western"><surname>Tebby</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cronin</surname><given-names>M.T.D.</given-names></name><name name-style="western"><surname>Tissot</surname><given-names>S.</given-names></name><name name-style="western"><surname>Andres</surname><given-names>S.</given-names></name><name name-style="western"><surname>Brignon</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Frewer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Georgiou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mattask</surname><given-names>K.</given-names></name><name name-style="western"><surname>Vergnaud</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Peijnenburg</surname><given-names>W.</given-names></name><name name-style="western"><surname>Capri</surname><given-names>E.</given-names></name><name name-style="western"><surname>Marchis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wilks</surname><given-names>M.F.</given-names></name></person-group><article-title>Perspectives for integrating human and environmental risk assessment and synergies with socio-economic analysis</article-title><source>Sci. Total Environ.</source><volume>456&#8211;457</volume><year>2013</year><fpage>307</fpage><lpage>316</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.scitotenv.2013.03.099</pub-id><pub-id pub-id-type="pmid">23624004</pub-id></element-citation></ref><ref id="b0210"><label>43</label><element-citation publication-type="journal" id="h0210"><person-group person-group-type="author"><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>S.</given-names></name><name name-style="western"><surname>B&#233;liveau</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name></person-group><article-title>Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures</article-title><source>Environ. Health Perspect.</source><volume>110</volume><year>2002</year><fpage>989</fpage><lpage>994</lpage><pub-id pub-id-type="pmid">12634130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.02110s6989</pub-id><pub-id pub-id-type="pmcid">PMC1241283</pub-id></element-citation></ref><ref id="b0215"><label>44</label><element-citation publication-type="journal" id="h0215"><person-group person-group-type="author"><name name-style="western"><surname>Curtis</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>W.L.</given-names></name><name name-style="western"><surname>Mehendale</surname><given-names>H.M.</given-names></name></person-group><article-title>Potentiation of the hepatotoxicity of carbon tetrachloride following preexposure to chlordecone (Kepone) in the male rat</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>51</volume><year>1979</year><fpage>283</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">93792</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0041-008x(79)90471-x</pub-id></element-citation></ref><ref id="b0220"><label>45</label><element-citation publication-type="journal" id="h0220"><person-group person-group-type="author"><name name-style="western"><surname>Paustenbach</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Clewell</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Gargas</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name></person-group><article-title>A physiologically based pharmacokinetic model for inhaled carbon tetrachloride</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>96</volume><year>1988</year><fpage>191</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">3143166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0041-008x(88)90080-4</pub-id></element-citation></ref><ref id="b0225"><label>46</label><element-citation publication-type="journal" id="h0225"><person-group person-group-type="author"><name name-style="western"><surname>El-masri</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Sabados</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Constan</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Benjamin</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Mehendale</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.S.H.</given-names></name></person-group><article-title>Physiologically based pharmacokinetic/pharmacodynamic modeling of the toxicologic interaction between carbon tetrachloride and Kepone</article-title><source>Arch. Toxicol.</source><volume>70</volume><year>1996</year><fpage>704</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">8896716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002040050331</pub-id></element-citation></ref><ref id="b0230"><label>47</label><element-citation publication-type="journal" id="h0230"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Johanson</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ichihara</surname><given-names>G.</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kamijima</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ono</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name></person-group><article-title>Physiologically based pharmacokinetic modeling of metabolic interactions between n-hexane and toluene in humans</article-title><source>J Occup Health</source><volume>40</volume><year>1998</year><fpage>293</fpage><lpage>330</lpage></element-citation></ref><ref id="b0235"><label>48</label><element-citation publication-type="journal" id="h0235"><person-group person-group-type="author"><name name-style="western"><surname>Perbellini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Leone</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fracasso</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Brugnone</surname><given-names>F.</given-names></name><name name-style="western"><surname>Venturini</surname><given-names>M.S.</given-names></name></person-group><article-title>Metabolic interaction between n-hexane and toluene in vivo and in vitro</article-title><source>Int. Arch. Occup. Environ. Health</source><volume>50</volume><year>1982</year><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">7174120</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00377831</pub-id></element-citation></ref><ref id="b0240"><label>49</label><element-citation publication-type="journal" id="h0240"><person-group person-group-type="author"><name name-style="western"><surname>Perbellini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mozzo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Brugnone</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zedde</surname><given-names>A.</given-names></name></person-group><article-title>Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine</article-title><source>Br. J. Ind. Med.</source><volume>43</volume><year>1986</year><fpage>760</fpage><lpage>768</lpage><pub-id pub-id-type="pmid">3790456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/oem.43.11.760</pub-id><pub-id pub-id-type="pmcid">PMC1007749</pub-id></element-citation></ref><ref id="b0245"><label>50</label><element-citation publication-type="journal" id="h0245"><person-group person-group-type="author"><name name-style="western"><surname>Perbellini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mozzo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Olivato</surname><given-names>D.</given-names></name><name name-style="western"><surname>Brugnone</surname><given-names>F.</given-names></name></person-group><article-title>&#8220;Dynamic&#8221; biological exposure indexes for n-hexane and 2,5-hexanedione, suggested by a physiologically based pharmacokinetic model</article-title><source>Am. Ind. Hyg. Assoc. J.</source><volume>51</volume><year>1990</year><fpage>356</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">2382638</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15298669091369781</pub-id></element-citation></ref><ref id="b0250"><label>51</label><element-citation publication-type="journal" id="h0250"><person-group person-group-type="author"><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name><name name-style="western"><surname>Charest-Tardif</surname><given-names>G.</given-names></name></person-group><article-title>The importance of measured end-points in demonstrating the occurrence of interactions: a case study with methylchloroform and m-xylene</article-title><source>Toxicol. Sci.</source><volume>49</volume><year>1999</year><fpage>312</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">10416277</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/49.2.312</pub-id></element-citation></ref><ref id="b0255"><label>52</label><element-citation publication-type="journal" id="h0255"><person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>N.</given-names></name><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name></person-group><article-title>Toxicokinetic Modeling of the combined exposure to toluene and n-hexane in rats and humans</article-title><source>J. Occup. Health</source><volume>41</volume><year>1999</year><fpage>95</fpage><lpage>103</lpage></element-citation></ref><ref id="b0260"><label>53</label><element-citation publication-type="journal" id="h0260"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Droz</surname><given-names>P.O.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name></person-group><article-title>Biological monitoring of workers exposed to ethylbenzene and co-exposed to xylene</article-title><source>Int. Arch. Occup. Environ. Health</source><volume>74</volume><year>2000</year><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s004200000181</pub-id><pub-id pub-id-type="pmid">11196078</pub-id></element-citation></ref><ref id="b0265"><label>54</label><element-citation publication-type="journal" id="h0265"><person-group person-group-type="author"><name name-style="western"><surname>Isaacs</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Evans</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>T.R.</given-names></name></person-group><article-title>Visualization-based analysis for a mixed-inhibition binary PBPK model: determination of inhibition mechanism</article-title><source>J. Pharmacokinet. Pharmacodyn.</source><volume>31</volume><year>2004</year><fpage>215</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">15518245</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1023/b:jopa.0000039565.11358.94</pub-id></element-citation></ref><ref id="b0270"><label>55</label><element-citation publication-type="journal" id="h0270"><person-group person-group-type="author"><name name-style="western"><surname>Fisher</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lumpkin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mahle</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bruckner</surname><given-names>J.V.</given-names></name><name name-style="western"><surname>El-Masri</surname><given-names>H.A.</given-names></name></person-group><article-title>PBPK modeling of the metabolic interactions of carbon tetrachloride and tetrachloroethylene in B6C3F1 mice</article-title><source>Environ. Toxicol. Pharmacol.</source><volume>16</volume><year>2004</year><fpage>93</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">21782696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.etap.2003.10.006</pub-id></element-citation></ref><ref id="b0275"><label>56</label><element-citation publication-type="journal" id="h0275"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Ou</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.S.H.</given-names></name></person-group><article-title>Comparison of pharmacokinetic interactions and physiologically based pharmacokinetic modelling of PCB 153 and PCB 126 in nonpregnant mice, lactating mice, and suckling pups</article-title><source>Toxicol. Sci.</source><volume>65</volume><year>2002</year><fpage>26</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">11752682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/65.1.26</pub-id></element-citation></ref><ref id="b0280"><label>57</label><element-citation publication-type="journal" id="h0280"><person-group person-group-type="author"><name name-style="western"><surname>Lutz</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Dedrick</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Eling</surname><given-names>T.E.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>M.W.</given-names></name></person-group><article-title>A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat</article-title><source>Drug Metab. Dispos.</source><volume>5</volume><year>1977</year><fpage>386</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">19218</pub-id></element-citation></ref><ref id="b0285"><label>58</label><element-citation publication-type="journal" id="h0285"><person-group person-group-type="author"><name name-style="western"><surname>El-masri</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Mumtaz</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Yushak</surname><given-names>M.L.</given-names></name></person-group><article-title>Application of physiologically-based pharmacokinetic modeling to investigate the toxicological interaction between chlorpyrifos and parathion in the rat</article-title><source>Environ. Toxicol. Pharmacol.</source><volume>16</volume><year>2004</year><fpage>57</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">21782694</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.etap.2003.10.002</pub-id></element-citation></ref><ref id="b0290"><label>59</label><element-citation publication-type="journal" id="h0290"><person-group person-group-type="author"><name name-style="western"><surname>Timchalk</surname><given-names>C.</given-names></name><name name-style="western"><surname>Poet</surname><given-names>T.S.</given-names></name></person-group><article-title>Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat</article-title><source>NeuroToxicology</source><volume>29</volume><year>2008</year><fpage>428</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">18394709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuro.2008.02.004</pub-id></element-citation></ref><ref id="b0295"><label>60</label><element-citation publication-type="journal" id="h0295"><person-group person-group-type="author"><name name-style="western"><surname>Punt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Freidig</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Delatour</surname><given-names>T.</given-names></name><name name-style="western"><surname>Scholz</surname><given-names>G.</given-names></name><name name-style="western"><surname>Boersma</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Schilter</surname><given-names>B.</given-names></name><name name-style="western"><surname>Van Bladeren</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Rietjens</surname><given-names>I.M.C.M.</given-names></name></person-group><article-title>A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>231</volume><year>2008</year><fpage>248</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">18539307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2008.04.011</pub-id></element-citation></ref><ref id="b0300"><label>61</label><element-citation publication-type="journal" id="h0300"><person-group person-group-type="author"><name name-style="western"><surname>Haddad</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name><name name-style="western"><surname>Viau</surname><given-names>C.</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name></person-group><article-title>A modeling approach to account for toxicokinetic interactions in the calculation of biological hazard index for chemical mixtures</article-title><source>Toxicol. Lett.</source><volume>108</volume><year>1999</year><fpage>303</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">10511275</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-4274(99)00102-2</pub-id></element-citation></ref><ref id="b0305"><label>62</label><element-citation publication-type="journal" id="h0305"><person-group person-group-type="author"><name name-style="western"><surname>Dennison</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Bigelow</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>Mumtaz</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Dobrev</surname><given-names>I.D.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.S.H.</given-names></name></person-group><article-title>Evaluation of potential toxicity from co-exposure to three CNS depressants (toluene, ethylbenzene, and xylene) under resting and working conditions using PBPK Modeling</article-title><source>J. Occup. Environ. Hygiene</source><volume>2</volume><year>2005</year><fpage>127</fpage><lpage>135</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15459620590916198</pub-id><pub-id pub-id-type="pmid">15764536</pub-id></element-citation></ref><ref id="b0310"><label>63</label><element-citation publication-type="journal" id="h0310"><person-group person-group-type="author"><name name-style="western"><surname>Haddad</surname><given-names>S.</given-names></name><name name-style="western"><surname>Poulin</surname><given-names>P.</given-names></name><name name-style="western"><surname>Funk</surname><given-names>C.</given-names></name></person-group><article-title>Extrapolating In vitro Metabolic Interactions to Isolated Perfused Liver: Predictions of Metabolic Interactions between R-Bufuralol, Bunitrolol, and Debrisoquine</article-title><source>J. Pharm. Sci.</source><volume>99</volume><year>2010</year><fpage>4406</fpage><lpage>4426</lpage><pub-id pub-id-type="pmid">20310018</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jps.22136</pub-id></element-citation></ref><ref id="b0315"><label>64</label><element-citation publication-type="journal" id="h0315"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>A.</given-names></name></person-group><article-title>An investigation of the neurobehavioural effects on workers exposed to organic solvents</article-title><source>Occup. Med.</source><volume>40</volume><year>1990</year><fpage>94</fpage><lpage>96</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/occmed/40.3.94</pub-id><pub-id pub-id-type="pmid">2214700</pub-id></element-citation></ref><ref id="b0320"><label>65</label><element-citation publication-type="journal" id="h0320"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>O.</given-names></name><name name-style="western"><surname>Seiji</surname><given-names>K.</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kasahara</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nakatsuka</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>M.</given-names></name></person-group><article-title>Mutual metabolic suppression between benzene and toluene in man</article-title><source>Int. Arch. Occup. Environ. Health</source><volume>60</volume><year>1988</year><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">3350599</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00409373</pub-id></element-citation></ref><ref id="b0325"><label>66</label><element-citation publication-type="journal" id="h0325"><person-group person-group-type="author"><name name-style="western"><surname>Ikeda</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ohtsuji</surname><given-names>H.</given-names></name><name name-style="western"><surname>Imamura</surname><given-names>T.</given-names></name></person-group><article-title>In vivo suppression of benzene and styrene oxidation by co-administered toluene in rats and effects of phenobarbital</article-title><source>Xenobiotica</source><volume>2</volume><year>1972</year><fpage>101</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">5056809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00498257209111041</pub-id></element-citation></ref><ref id="b0330"><label>67</label><element-citation publication-type="journal" id="h0330"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nakajima</surname><given-names>T.</given-names></name></person-group><article-title>Dose-dependent metabolic interaction between benzene and toluene in vivo and in vitro</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>48</volume><year>1979</year><fpage>249</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">473174</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0041-008x(79)90030-9</pub-id></element-citation></ref><ref id="b0335"><label>68</label><element-citation publication-type="journal" id="h0335"><person-group person-group-type="author"><name name-style="western"><surname>Waller</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Evans</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Mckinney</surname><given-names>J.D.</given-names></name></person-group><article-title>Modeling the cytochrome P450-mediated metabolism of chlorinated volatile organic compounds</article-title><source>Drug Metab. Dispos.</source><volume>24</volume><year>1996</year><fpage>203</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">8742232</pub-id></element-citation></ref><ref id="b0340"><label>69</label><element-citation publication-type="journal" id="h0340"><person-group person-group-type="author"><name name-style="western"><surname>Knaak</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Dary</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Power</surname><given-names>F.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>C.B.</given-names></name><name name-style="western"><surname>Blancato</surname><given-names>J.N.</given-names></name></person-group><article-title>Physicochemical and biological data for the development of predictive organophosphorus pesticide QSARs and PBPK/PD models for human risk assessment</article-title><source>Crit. Rev. Toxicol.</source><volume>34</volume><year>2004</year><fpage>143</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">15112752</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10408440490432250</pub-id></element-citation></ref><ref id="b0345"><label>70</label><mixed-citation publication-type="other" id="h0345">S. Wang D.W. Zaharevitz R. Sharma V.E. Marquez N.E. Lewin DU, L., Blumberg, P. M. &amp; Milne, G. The discovery of novel, structurally diverse protein kinase C agonists through computer 3D-database pharmacophore search. Molecular modeling studies Journal of medicinal chemistry 37 1994 4479 4489.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/jm00052a007</pub-id><pub-id pub-id-type="pmid">7799398</pub-id></mixed-citation></ref><ref id="b0350"><label>71</label><element-citation publication-type="journal" id="h0350"><person-group person-group-type="author"><name name-style="western"><surname>Ekins</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bravi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Binkley</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gillespie</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Ring</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Wikel</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Wrighton</surname><given-names>S.A.</given-names></name></person-group><article-title>Three-and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors</article-title><source>J. Pharmacol. Exp. Ther.</source><volume>290</volume><year>1999</year><fpage>429</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">10381809</pub-id></element-citation></ref><ref id="b0355"><label>72</label><element-citation publication-type="journal" id="h0355"><person-group person-group-type="author"><name name-style="western"><surname>B&#233;liveau</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tardif</surname><given-names>R.</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name></person-group><article-title>Quantitative structure&#8211;property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>189</volume><year>2003</year><fpage>221</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">12791307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0041-008x(03)00129-7</pub-id></element-citation></ref><ref id="b0360"><label>73</label><element-citation publication-type="journal" id="h0360"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Govind</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tabak</surname><given-names>H.H.</given-names></name></person-group><article-title>Application of the group contribution method for predicting the toxicity of organic chemicals</article-title><source>Environ. Toxicol. Chem.</source><volume>11</volume><year>1992</year><fpage>631</fpage><lpage>636</lpage></element-citation></ref><ref id="b0365"><label>74</label><element-citation publication-type="journal" id="h0365"><person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>K.</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>K.</given-names></name></person-group><article-title>An integrated QSAR-PBPK modelling approach for predicting the inhalation toxicokinetics of mixtures of volatile organic chemicals in the rat</article-title><source>SAR QSAR Environ. Res.</source><volume>22</volume><year>2011</year><fpage>107</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">21391144</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/1062936X.2010.548350</pub-id></element-citation></ref><ref id="b9010"><label>75</label><element-citation publication-type="journal" id="h9010"><person-group person-group-type="author"><name name-style="western"><surname>Dallas</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Gallo</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Ramanathan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Muralidhara</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bruckner</surname><given-names>J.V.</given-names></name></person-group><article-title>Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>110</volume><year>1991</year><fpage>303</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">1891776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0041-008x(05)80013-4</pub-id></element-citation></ref><ref id="b9015"><label>76</label><element-citation publication-type="journal" id="h9015"><person-group person-group-type="author"><name name-style="western"><surname>Droz</surname><given-names>P.O.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Cumberland</surname><given-names>W.G.</given-names></name><name name-style="western"><surname>Berode</surname><given-names>M.</given-names></name></person-group><article-title>Variability in biological monitoring of solvent exposure. I. Development of a population physiological model</article-title><source>Brit. J Ind. Med.</source><volume>46</volume><year>1989</year><fpage>447</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">2765418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/oem.46.7.447</pub-id><pub-id pub-id-type="pmcid">PMC1009808</pub-id></element-citation></ref></ref-list><sec id="s0090" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="p0230">The following are the Supplementary data to this article:<supplementary-material content-type="local-data" id="m0005" position="float" orientation="portrait"><caption><title>Supplementary Data 1</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc1.xlsx" position="float" orientation="portrait"/></supplementary-material></p></sec><fn-group><fn id="s0085" fn-type="supplementary-material"><label>Appendix A</label><p id="p0225">Supplementary data to this article can be found online at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.comtox.2018.09.001" id="ir005">https://doi.org/10.1016/j.comtox.2018.09.001</ext-link>.</p></fn></fn-group></back></article></pmc-articleset>